Holen Sie sich die Stockscreener-App
0.7652
1.47%
-0.0068
Schlusskurs vom Vortag:
$0.772
Offen:
$0.769
24-Stunden-Volumen:
872.20K
Relative Volume:
0.18
Marktkapitalisierung:
$166.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-111.13M
KGV:
-0.5797
EPS:
-1.32
Netto-Cashflow:
$-91.53M
1W Leistung:
+3.53%
1M Leistung:
-46.05%
6M Leistung:
+13.34%
1J Leistung:
-46.43%
1-Tages-Spanne:
$0.7511
$0.792
1-Wochen-Bereich:
$0.7181
$0.8194
52-Wochen-Spanne:
$0.36
$2.35
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Firmenname
Tenaya Therapeutics Inc
Sektor
Branche
Telefon
415-865-2066
Adresse
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Vergleichen Sie TNYA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.7702 | 167.14M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.17 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.41 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.74 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.40 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.73 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-10 | Eingeleitet | William Blair | Outperform |
| 2023-11-30 | Eingeleitet | Leerink Partners | Outperform |
| 2022-06-15 | Eingeleitet | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Aktie (TNYA) Neueste Nachrichten
Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones - Yahoo Finance
Why Tenaya Therapeutics Inc. stock could see breakout soonJuly 2025 Drop Watch & Consistent Income Trade Recommendations - ulpravda.ru
Published on: 2026-01-09 09:18:13 - ulpravda.ru
Is Tenaya Therapeutics Inc. stock supported by strong fundamentalsWall Street Watch & Safe Entry Trade Signal Reports - ulpravda.ru
What insider trading reveals about Tenaya Therapeutics Inc. stockEntry Point & Consistent Return Investment Signals - ulpravda.ru
Will Tenaya Therapeutics Inc. stock benefit from infrastructure spending2025 Macro Impact & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Published on: 2026-01-09 03:34:26 - moha.gov.vn
Why Tenaya Therapeutics Inc. stock is trending among retail tradersJuly 2025 Rallies & Free Accurate Trade Setup Notifications - ulpravda.ru
How Tenaya Therapeutics Inc. stock reacts to Fed rate cuts2026 world cup usa national team qualification key players low block defense match prediction tactical review - ulpravda.ru
Tenaya Therapeutics announces orderly board leadership transition - MSN
Tenaya Therapeutics Inc. (TNYA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Buy Signal: Is Tenaya Therapeutics Inc stock supported by strong fundamentalsPortfolio Update Report & Daily Volume Surge Signals - moha.gov.vn
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Gene therapy genie back in the bottle? - BioWorld MedTech
Tenaya Therapeutics price target lowered to $4 from $6 at Canaccord - MSN
Why Tenaya Therapeutics Inc. stock is rated strong buy2025 Price Momentum & Free Expert Verified Stock Movement Alerts - Bölüm Sonu Canavarı
Tenaya Therapeutics, Inc.(NasdaqGS: TNYA) added to NASDAQ Biotechnology Index - MarketScreener
Buyout Rumor: Why Tenaya Therapeutics Inc stock is recommended by analystsMarket Activity Report & Reliable Trade Execution Plans - moha.gov.vn
Is International Seaways Inc stock attractive for ETFsMarket Risk Analysis & Smart Money Movement Tracker - moha.gov.vn
Leerink Partners Reaffirms Their Buy Rating on Tenaya Therapeutics (TNYA) - The Globe and Mail
Will Tenaya Therapeutics Inc. stock outperform growth indexesWeekly Market Outlook & Long Hold Capital Preservation Plans - Улправда
Is Tenaya Therapeutics Inc. stock positioned for long term growth2025 Performance Recap & Low Drawdown Momentum Ideas - Улправда
Will Tenaya Therapeutics Inc. stock remain a Wall Street favorite2025 Top Gainers & Consistent Profit Trading Strategies - DonanımHaber
Will Tenaya Therapeutics Inc. stock deliver shareholder valueQuarterly Investment Review & Expert-Curated Trade Recommendations - DonanımHaber
Canaccord Genuity Keeps Their Buy Rating on Tenaya Therapeutics (TNYA) - The Globe and Mail
Sell Signal: What catalysts could drive Tenaya Therapeutics Inc. stock higher2025 Key Lessons & Proven Capital Preservation Tips - Улправда
Tenaya Therapeutics stock price target lowered to $5 at Canaccord By Investing.com - Investing.com Canada
FY2025 Earnings Forecast for TNYA Issued By Lifesci Capital - MarketBeat
Tenaya Therapeutics stock price target lowered to $5 at Canaccord - Investing.com India
Wilson Sonsini Advises Tenaya Therapeutics on Pricing of Public Offering - Wilson Sonsini
H.C. Wainwright lowers Tenaya Therapeutics stock price target to $3 on ARVC trial data By Investing.com - Investing.com Australia
Tenaya fundraising follows resolution of clinical hold - The Pharma Letter
H.C. Wainwright lowers Tenaya Therapeutics stock price target to $3 on ARVC trial data - Investing.com Nigeria
Tenaya Therapeutics announces proposed public offering - MSN
Tenaya Therapeutics price target lowered to $3 from $5 at HC Wainwright - MSN
Tenaya Therapeutics (TNYA) Is Down 39.7% After Cardiac Gene Therapy Milestones And $60M FundraiseWhat's Changed - Yahoo Finance
Tenaya Therapeutics announces clinical hold on MyPEAK-1 trial lifted by FDA - MSN
Tenaya Therapeutics (NASDAQ:TNYA) Given New $3.00 Price Target at HC Wainwright - MarketBeat
Chardan Capital Lowers Tenaya Therapeutics (NASDAQ:TNYA) Price Target to $8.00 - MarketBeat
Tenaya Therapeutics Announces Public Offering Pricing - The Globe and Mail
Chardan Capital Maintains Tenaya Therapeutics (TNYA) Buy Recommendation - Nasdaq
HC Wainwright & Co. Maintains Tenaya Therapeutics (TNYA) Buy Recommendation - Nasdaq
Tenaya Therapeutics (NASDAQ: TNYA) details $60 million unit and warrant sale - Stock Titan
Pharma News: Will Tenaya Therapeutics Inc stock remain a Wall Street favorite2025 Market Sentiment & Weekly Return Optimization Plans - moha.gov.vn
Tenaya Stock Plunges After $60 Million Equity Offering - Sahm
Tenaya Stock Drops After Announcing $60M Equity OfferingTenaya Therapeutics (NASDAQ:TNYA) - Benzinga
Tenaya Therapeutics (TNYA) Price Target Lowered by HC Wainwright & Co. | TNYA Stock News - GuruFocus
Tenaya Therapeutics slumps after $60 million share sale - TradingView — Track All Markets
Tenaya Therapeutics plans to offer stock and warrant units By Investing.com - Investing.com India
Tenaya Therapeutics Prices 50 Mln Unit Offering At $60 Mln, Clinical Hold Lifted On TN-201 - Nasdaq
Tenaya Therapeutics announces positive data from Phase 1b/2 trial - Traders Union
Finanzdaten der Tenaya Therapeutics Inc-Aktie (TNYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tenaya Therapeutics Inc-Aktie (TNYA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer |
Nov 17 '25 |
Sale |
1.33 |
2,877 |
3,826 |
169,926 |
| Ali Faraz | Chief Executive Officer |
Nov 17 '25 |
Sale |
1.33 |
3,126 |
4,158 |
299,666 |
| Higa Tomohiro | SVP, Finance |
Aug 18 '25 |
Sale |
1.25 |
2,962 |
3,711 |
95,338 |
| Tingley Whittemore | Chief Medical Officer |
Aug 18 '25 |
Sale |
1.25 |
5,053 |
6,331 |
172,803 |
| Ali Faraz | Chief Executive Officer |
Aug 18 '25 |
Sale |
1.25 |
14,533 |
18,210 |
302,792 |
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):